Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Argos Therapeutics Inc (NASDAQ:ARGS)

6.16
Delayed Data
As of Aug 28
 +0.01 / +0.16%
Today’s Change
4.11
Today|||52-Week Range
10.80
-38.40%
Year-to-Date

Today’s Trading

Previous close6.15
Today’s open6.17
Day’s range6.09 - 6.20
Volume24,252
Average volume (3 months)35,478
Market cap$127.4M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+87.30%
Earnings growth (this year)-10.74%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.36%
P/E ratioNM
Price/Sales87.98
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
AKAOAchaogen Inc+0.34+5.11%
TNXPTonix Pharmaceutical...+0.09+1.37%
EPRSEPIRUS Biopharmaceut...+0.35+7.07%
REPHRecro Pharma Inc+1.00+7.64%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.90
Annual revenue (last year)$2.0M
Annual profit (last year)-$53.3M
Net profit margin-2,700.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Operating Officer &
VP-Manufacturing
Frederick M. Miesowicz
Corporate headquarters
Durham, North Carolina

Forecasts

Partner Offers